Tagged: protocol

Metrics, Motivation and Site Performance in Clinical Trials

I am pleased to announce a second guest writer for Trials without Tribulations. Allyson Cygnarowicz is a project manager at Health Decisions with more than 13 years of experience in clinical research, including phases I through IV pharmaceutical studies and all levels of pre- and post-market device studies. She has a particularly strong background in… Read more »

The Importance of Information-Flow: The Case of the Thwarted Startup

In my last post, I discussed the cultural problem of excessive risk-aversion preventing pharma and CROs from using methods that could improve R&D productivity. This issue is never more evident than when applied to the critical area of information flow and decision making. Here’s an example of how a potentially important drug failed in a… Read more »